Filiz Koşar

835 total citations
52 papers, 607 citations indexed

About

Filiz Koşar is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Filiz Koşar has authored 52 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Filiz Koşar's work include Lung Cancer Diagnosis and Treatment (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Pleural and Pulmonary Diseases (8 papers). Filiz Koşar is often cited by papers focused on Lung Cancer Diagnosis and Treatment (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers) and Pleural and Pulmonary Diseases (8 papers). Filiz Koşar collaborates with scholars based in Türkiye, Kuwait and United Kingdom. Filiz Koşar's co-authors include İbrahim Şahin, Süleyman Savaş Hacıevliyagil, Gazi Gülbaş, Hakan Günen, Erkan Pehlivan, Levent Cem Mutlu, Özkan Kızkın, Çağlar Çuhadaroğlu, Remise Gelışgen and Hafize Uzun and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Human Reproduction.

In The Last Decade

Filiz Koşar

48 papers receiving 586 citations

Peers

Countries citing papers authored by Filiz Koşar

Since Specialization

Citations

This map shows the geographic impact of Filiz Koşar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filiz Koşar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filiz Koşar more than expected).

Fields of papers citing papers by Filiz Koşar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filiz Koşar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filiz Koşar. The network helps show where Filiz Koşar may publish in the future.

Co-authorship network of co-authors of Filiz Koşar

This figure shows the co-authorship network connecting the top 25 collaborators of Filiz Koşar. A scholar is included among the top collaborators of Filiz Koşar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filiz Koşar. Filiz Koşar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report 2023 ·Tuberkuloz ve Toraks ·(unknown), (unknown), (unknown), (unknown), (unknown), Filiz Koşar	2
2	The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment 2021 ·TURKISH JOURNAL OF MEDICAL SCIENCES ·Halit Çınarka, Gülşah Günlüoğlu, (unknown), (unknown), (unknown), Filiz Koşar, (unknown), (unknown), (unknown), (unknown), Sedat Altın, Erdoğan Çetınkaya	3
3	Area under flow-volume loop may predict severe exacerbation in COPD patients with high grade of dyspnea 2021 ·Respiratory Physiology & Neurobiology ·(unknown), (unknown), (unknown), (unknown), Filiz Koşar	0
4	Electromyographic and sonographic assessment of diaphragm dysfunction in patients who recovered from the COVID-19 pneumonia 2021 ·Tuberkuloz ve Toraks ·(unknown), Şenay Aydın, (unknown), (unknown), Filiz Koşar	4
5	Determining emphysema in adult patients with COPD-bronchiectasis overlap using a novel spirometric parameter: area under the forced expiratory flow-volume loop 2020 ·Expert Review of Respiratory Medicine ·(unknown), (unknown), (unknown), Filiz Koşar	2
6	Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease 2019 ·SHILAP Revista de lepidopterología ·Pınar Uysal, Gönül Şimşek, (unknown), Volkan Sözer, (unknown), (unknown), Çağlar Çuhadaroğlu, Filiz Koşar, Remise Gelışgen, (unknown)	1
7	<p>Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease</p> 2019 ·International Journal of COPD ·(unknown), Gönül Şimşek, (unknown), Volkan Sözer, (unknown), (unknown), Çağlar Çuhadaroğlu, Filiz Koşar, Remise Gelışgen, Hafize Uzun	17
8	Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: A comparative study 2019 ·Journal of Medical Biochemistry ·Füsun Şahin, Filiz Koşar, (unknown), (unknown), (unknown)	40
9	Burden Of Community-Acquired Pneumonia In Adults Over 18 Years Of Age 2015 ·Value in Health ·Çağlar Çuhadaroğlu, (unknown), (unknown), (unknown), Filiz Koşar	17
10	Central airway obstruction due to malignant fibrous histiocytoma metastasis in a case with Mounier-Kuhn syndrome 2012 ·Tuberkuloz ve Toraks ·Levent Dalar, Emel Eryüksel, Filiz Koşar, (unknown), Halide Nur Ürer, Sinem Nedime Sökücü, Sedat Altın	2
11	The role of feed regulating peptides on weight loss in patients with pulmonary tuberculosis 2012 ·Clinical Biochemistry ·(unknown), Hayriye Erman, (unknown), Filiz Koşar, (unknown), Remise Gelışgen, Gönül Şimşek, Hafize Uzun	16
12	False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer 2011 ·European Journal of Cardio-Thoracic Surgery ·İlker İskender, (unknown), (unknown), (unknown), (unknown), Filiz Koşar, Altan Kır	13
13	Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis? 2010 ·Archives of Medical Science ·Bayram Kıran, Tülin Çağatay, (unknown), Filiz Koşar, (unknown), (unknown), (unknown), (unknown)	20
14	The Value of Surgical Resection in Patients with Multidrug Resistant Tuberculosis 2009 ·The Thoracic and Cardiovascular Surgeon ·(unknown), Filiz Koşar, Recep Demirhan, (unknown), (unknown)	12
15	Multiple endobronchial lipomas which were treated by bronchoscopical resection 2008 ·Respiratory Medicine CME ·(unknown), Levent Karasulu, Filiz Koşar, Sedat Altın, Halide Nur Ürer	1
16	Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: A phase II study 2007 ·Lung Cancer ·Adnan Aydıner, (unknown), (unknown), Filiz Koşar, Atilla Gürses, Akif Turna, Aziz Yazar, Şükrü Dilege, Tuncay Göksel, Alpaslan Çakan	9
17	The Impact of Immunohistochemical Detection of Positive Lymph Nodes in Early Stage Lung Cancer 2006 ·The Thoracic and Cardiovascular Surgeon ·Çağatay Tezel, (unknown), (unknown), (unknown), Filiz Koşar, (unknown), (unknown), (unknown)	15
18	Levels of tumour necrosis factor‐α and IL‐1α in newly diagnosed and multidrug resistant tuberculosis 2005 ·Respirology ·Tülin Çağatay, (unknown), (unknown), (unknown), Filiz Koşar, (unknown)	15
19	Factors affecting survival of hospitalised patients with COPD 2005 ·European Respiratory Journal ·Hakan Günen, Süleyman Savaş Hacıevliyagil, Filiz Koşar, Levent Cem Mutlu, Gazi Gülbaş, Erkan Pehlivan, İbrahim Şahin, Özkan Kızkın	205
20	Determination of the Etiological Organism During Acute Exacerbations of COPD and Efficacy of Azithromycin, Ampicillin-Sulbactam, Ciprofloxacin and Cefaclor 1999 ·Journal of Chemotherapy ·(unknown), Bülent Tutluoğlu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hatice Türker, Mustafa Erelel, Ahmet Ïlvan, (unknown), (unknown), Filiz Koşar, (unknown), (unknown), (unknown), (unknown), Mehmet Akman, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact